Total abdominal 18F-FDG uptake reflects intestinal adenoma burden in Apc mutant mice

Journal of Nuclear Medicine

Volumn 52, Issue 3, 2011, Pages 431-436

  Heijink, Dianne M ^a   Kleibeuker, Jan H ^a   Nagengast, Wouter B ^a   Oosterhuis, Dorenda ^a   Brouwers, Adrienne H ^a   Koornstra, Jan J ^a   De Jong, Steven ^a   De Vries, Elisabeth G E ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

18F FDG PET; Animal imaging; ApcMin mice; Colorectal adenomas; Oncology; PET

Indexed keywords

APC PROTEIN; FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER 1; KI 67 ANTIGEN; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLORECTAL ADENOMA; CONTROLLED STUDY; DISEASE MODEL; DRUG DISTRIBUTION; DRUG UPTAKE; EX VIVO STUDY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTESTINE RESECTION; MALE; MICROSCOPY; MOUSE; MOUSE MUTANT; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME; ABDOMEN; ADENOMA; ANIMAL; C57BL MOUSE; COLORECTAL TUMOR; GENETICS; METABOLISM; SCINTISCANNING; TISSUE DISTRIBUTION; TUMOR SUPPRESSOR GENE;

ABDOMEN; ADENOMA; ANIMALS; COLORECTAL NEOPLASMS; FLUORODEOXYGLUCOSE F18; GENES, APC; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION;

EID: 79952785702     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.083956     Document Type: Article

References (31)

1. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525-532.
2. Nicum S, Midgley R, Kerr DJ. Colorectal cancer. Acta Oncol. 2003;42:263-275. (Pubitemid 36851143)
3. Arber N, Levin B. Chemoprevention of colorectal neoplasia: the potential for personalized medicine. Gastroenterology. 2008;134:1224-1237. (Pubitemid 351451998)
4. Ulrich CM, Bigler J, Potter JD. Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nat Rev Cancer. 2006;6:130-140. (Pubitemid 43361545)
5. McCart AE, Vickaryous NK, Silver A. Apc mice: models, modifiers and mutants. Pathol Res Pract. 2008;204:479-490.
6. Corpet DE, Pierre F. How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and men. Eur J Cancer. 2005;41:1911-1922. (Pubitemid 41557677)
7. Gambhir SS. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer. 2002;2:683-693. (Pubitemid 37328919)
8. Gollub MJ, Akhurst T, Markowitz AJ, et al. Combined CT colonography and 18F-FDG PET of colon polyps: potential technique for selective detection of cancer and precancerous lesions. AJR. 2007;188:130-138. (Pubitemid 46012499)
9. van Kouwen MC, Drenth JP, van Krieken JH, et al. Ability of FDG-PET to detect all cancers in patients with familial adenomatous polyposis, and impact on clinical management. Eur J Nucl Med Mol Imaging. 2006;33:270-274.
10. Gutman F, Alberini JL, Wartski M, et al. Incidental colonic focal lesions detected by FDG PET/CT. AJR. 2005;185:495-500.
11. 18F)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study. J Clin Oncol. 2005;23:3713-3717.
12. Yasuda S, Fujii H, Nakahara T, et al. 18F-FDG PET detection of colonic adenomas. J Nucl Med. 2001;42:989-992. (Pubitemid 32595293)
13. Drenth JP, Nagengast FM, Oyen WJ. Evaluation of (pre-)malignant colonic abnormalities: endoscopic validation of FDG-PET findings. Eur J Nucl Med. 2001;28:1766-1769.
14. Arslan N, Dehdashti F, Siegel BA. FDG uptake in colonic villous adenomas. Ann Nucl Med. 2005;19:331-334. (Pubitemid 41105136)
15. 18F-FDG uptake: incidence, localization patterns, and clinical significance. J Nucl Med. 2005;46:758-762.
16. Hemandas AK, Robson NK, Hickish T, Talbot RW. Colorectal tubulovillous adenomas identified on fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scans. Colorectal Dis. 2008;10:386-389. (Pubitemid 351524258)
17. Mainenti PP, Salvatore B, D'Antonio D, et al. PET/CT colonography in patients with colorectal polyps: a feasibility study. Eur J Nucl Med Mol Imaging. 2007; 34:1594-1603. (Pubitemid 47476912)
18. Nakajo M, Jinnouchi S, Tashiro Y, et al. Effect of clinicopathologic factors on visibility of colorectal polyps with FDG PET. AJR. 2009;192:754-760.
19. Friedland S, Soetikno R, Carlisle M, Taur A, Kaltenbach T, Segall G. 18-Fluorodeoxyglucose positron emission tomography has limited sensitivity for colonic adenoma and early stage colon cancer. Gastrointest Endosc. 2005;61:395-400. (Pubitemid 40349032)
20. Beazer-Barclay Y, Levy DB, Moser AR, et al. Sulindac suppresses tumorigenesis in the Min mouse. Carcinogenesis. 1996;17:1757-1760. (Pubitemid 26280404)
21. 18F-FDG PET studies in mice. J Nucl Med. 2006;47:999-1006.
22. Zhang L, Ren X, Alt E, et al. Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosis. Nature. 2010;464:1058-1061.
23. 18F-FDG biodistribution and insulin levels in tumor-bearing mice. J Nucl Med. 2005;46:1531-1536.
24. Busquets L, Guillen H, DeFord ME, et al. Cathepsin E is a specific marker of dysplasia in APC mouse intestine. Tumour Biol. 2006;27:36-42. (Pubitemid 41832702)
25. Cooper HS, Everley L, Chang WC, et al. The role of mutant Apc in the development of dysplasia and cancer in the mouse model of dextran sulfate sodiuminduced colitis. Gastroenterology. 2001;121:1407-1416. (Pubitemid 33140458)
26. Fuseler JW, Bedenbaugh A, Yekkala K, Baudino TA. Fractal and image analysis of the microvasculature in normal intestinal submucosa and intestinal polyps in Apc(Min/+) mice. Microsc Microanal. 2010;16:73-79.
27. Pandit-Taskar N, Schoder H, Gonen M, Larson SM, Yeung HW. Clinical significance of unexplained abnormal focal FDG uptake in the abdomen during whole-body PET. AJR. 2004;183:1143-1147. (Pubitemid 44185113)
28. Yeung AT, Patel BB, Li XM, et al. One-hit effects in cancer: altered proteome of morphologically normal colon crypts in familial adenomatous polyposis. Cancer Res. 2008;68:7579-7586.
29. Kuehle CA, Veit P, Antoch G, et al. Contrast-enhanced dark lumen PET/CT and MR colonography in a rodent polyp model: initial results with histopathologic correlation. AJR. 2005;185:1045-1047.
30. 18F]FDG-PET in the azoxymethane model. Nucl Med Biol. 2006;33:245-248.
31. 18F]fluoro-D-glucose and positron emission tomography. Gastroenterology. 2008;135:744-755.